Aminophylline

氨茶碱

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameAminophylline
Drug Alias Name氨苯碱aminophyllineAminophylline hydrate氨茶硷aminophyllinum +[12] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of Action3',5'-cyclic phosphodiesterase inhibitors
Targets3',5'-cyclic phosphodiesterase
Therapy Area/IndicationsAngina PectorisHeart ArrestAcute Kidney Injury +[11] 
Global Approved IndicationsAngina PectorisStrokePulmonary Edema +[6] 
Approved Indications in ChinaPulmonary Disease, Chronic ObstructiveAsthma
Original Approved Country/TerritoryJapan
Original Approved Date1950/10/01
Country/TerritoryCanadaUnited StatesThailand +[7] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesMercury Pharmaceuticals LtdEisai IncMahidol University +[4] 
Inactive CompaniesVancouver Coastal Health Research InstituteBeni Suef UniversityUniversity Of Virginia
Active IndicationsAngina PectorisAcute Kidney InjuryKidney Diseases +[8] 
Inactive IndicationsHeart ArrestUrinary Bladder NeoplasmsAnesthesia

Other Information

ATC CodeR03DA05
Related LinksWikipediaDrugBankKEGG